person · Reporting owner

PETERSON SANDRA E

Disclosed activity across 5 companies

Tapewire entity: 10678
SEC CIK: 0001192752

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
COVETRUS, INC.CVET · Entity 123087	Director	October 13, 2022	October 13, 2022
JOHNSON & JOHNSONJNJ · Entity 2722	Exec VP, Group WW Chairman	February 12, 2018	February 14, 2018
MICROSOFT CORPMSFT · Entity 1016	Director	September 10, 2026	September 11, 2026
Seaport Therapeutics, Inc.SPTX · Entity 4799	Director	April 30, 2026	May 04, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

COVETRUS, INC.

Report date October 13, 2022 · Filed October 13, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2022-10-13 transaction · row 1 1 source row Row 1 · 2022-10-13 · Disposition to issuer · Disposed 23,664 · Balance 0 F1: In connection with the merger of Corgi Merger Sub, Inc. ("Merger Sub") with and into the Issuer (the "Merger") pursuant to that certain Agreement and Plan of Merger, dated as of May 24, 2022, as amended from time to time, by and among the Issuer, Corgi Bidco, Inc. and Merger Sub, Inc. ("Merger Agreement"), shares of common stock, par value $0.01 per share, of the Issuer (the "Shares" and each a "Share"), were converted into the right to receive $21.00 per Share in cash, without interest (the "Merger Consideration").
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-10-13 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-10-13 · Disposition to issuer · Disposed 14,638 · Balance 0 F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock or the cash value thereof. F3: Pursuant to the Merger Agreement, outstanding RSUs vested (to the extent unvested) and were terminated and cancelled in exchange for the right to receive a lump sum cash payment equal to (x) the number of Shares underlying such RSUs immediately prior to the effective time of the Merger, multiplied by (y) the Merger Consideration.

Filing footnotes · ownership attribution and instrument terms

F1: In connection with the merger of Corgi Merger Sub, Inc. ("Merger Sub") with and into the Issuer (the "Merger") pursuant to that certain Agreement and Plan of Merger, dated as of May 24, 2022, as amended from time to time, by and among the Issuer, Corgi Bidco, Inc. and Merger Sub, Inc. ("Merger Agreement"), shares of common stock, par value $0.01 per share, of the Issuer (the "Shares" and each a "Share"), were converted into the right to receive $21.00 per Share in cash, without interest (the "Merger Consideration").

F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock or the cash value thereof.

F3: Pursuant to the Merger Agreement, outstanding RSUs vested (to the extent unvested) and were terminated and cancelled in exchange for the right to receive a lump sum cash payment equal to (x) the number of Shares underlying such RSUs immediately prior to the effective time of the Merger, multiplied by (y) the Merger Consideration.

JOHNSON & JOHNSON

Report date February 12, 2018 · Filed February 14, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	83,349	Ending reported balance After 2018-02-12 transaction · row 3 3 source rows · reconciled sequence Row 1 · 2018-02-12 · Exercise / conversion · Acquired 28,612 · Balance 93,867 F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Row 2 · 2018-02-12 · Grant · Acquired 10,301 · Balance 104,168 F2: Shares earned due to performance factor of 136% upon vesting of Performance Share Units and certification of performance results by the Board. Row 3 · 2018-02-12 · Tax withholding · Disposed 20,819 · Balance 83,349 F3: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.
Employee Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $129.51 · Expires 2028-02-12	Direct	93,959	Reported balance After 2018-02-12 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2018-02-12 · Grant · Acquired 93,959 · Balance 93,959 F4: Awarded under Issuer's Long-Term Incentive Plan.
Performance Share UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2018-02-12 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2018-02-12 · Exercise / conversion · Disposed 28,612 · Balance 0 F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.
Restricted Share UnitsSEC Table II · derivative / convertible security	Direct	4,714	Reported balance After 2018-02-12 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2018-02-12 · Grant · Acquired 4,714 · Balance 4,714 F5: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

F2: Shares earned due to performance factor of 136% upon vesting of Performance Share Units and certification of performance results by the Board.

F3: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.

F4: Awarded under Issuer's Long-Term Incentive Plan.

F5: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

MICROSOFT CORP

Report date September 10, 2026 · Filed September 11, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	26,511.947	Reported balance After 2026-09-10 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-09-10 · Grant · Acquired 48.902 · Balance 26,511.947 F1: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate. F3: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made 30 days after the date of the reporting person's separation from service to the Board of Directors.
Common StockSEC Table I · non-derivative	Direct	5,400	Reported balance Holding disclosure · report date 2026-09-10 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 5,400

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock.

F2: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate.

F3: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made 30 days after the date of the reporting person's separation from service to the Board of Directors.

Seaport Therapeutics, Inc.

Report date April 30, 2026 · Filed May 04, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.00 · Expires 2036-04-29	Direct	12,258	Reported balance After 2026-04-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-04-30 · Grant · Acquired 12,258 · Balance 12,258 F1: The shares underlying this option shall vest in full on April 30, 2027, subject to the Reporting Person's continued service on such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The shares underlying this option shall vest in full on April 30, 2027, subject to the Reporting Person's continued service on such vesting date.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Zymergen Inc.

Report date October 19, 2022 · Filed October 19, 2022

Section 16 reporting ended · disclosed 2022-10-19. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2022-10-19 transaction · row 1 1 source row Row 1 · 2022-10-19 · Disposition to issuer · Disposed 119,119 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of July 24, 2022 (the "Merger Agreement"), by and among Ginkgo Bioworks Holdings, Inc. ("Ginkgo"), Pepper Merger Subsidiary Inc. and the Issuer, each share of the Issuer's common stock was cancelled and converted into a right to receive 0.9179 of a share of Class A common stock of Ginkgo (the "Merger Consideration"), together with cash in lieu of any fractional shares of Class A common stock of Ginkgo. Immediately prior to the effective time of the merger (the "Effective Time"), all outstanding Issuer restricted stock units ("RSUs") vested in full pursuant to the terms of the agreements governing such Issuer RSUs. Pursuant to the Merger Agreement, immediately prior to the Effective Time, the Issuer RSUs were cancelled and converted into a right to receive the Merger Consideration in respect of such Issuer RSUs and cash in lieu of any fractional shares of Class A common stock of Ginkgo.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $9.60 · Expires 2030-05-01	Direct	0	Reported balance After 2022-10-19 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-10-19 · Disposition to issuer · Disposed 133,333 · Balance 0 F2: Immediately prior to the Effective Time, all outstanding Issuer stock options vested in full pursuant to the terms of the agreements governing such stock options. Pursuant to the Merger Agreement, at the Effective Time, each Issuer stock option with an exercise price per share equal to or greater than the Merger Consideration Value (as defined in the Merger Agreement) was cancelled for no consideration.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger, dated as of July 24, 2022 (the "Merger Agreement"), by and among Ginkgo Bioworks Holdings, Inc. ("Ginkgo"), Pepper Merger Subsidiary Inc. and the Issuer, each share of the Issuer's common stock was cancelled and converted into a right to receive 0.9179 of a share of Class A common stock of Ginkgo (the "Merger Consideration"), together with cash in lieu of any fractional shares of Class A common stock of Ginkgo. Immediately prior to the effective time of the merger (the "Effective Time"), all outstanding Issuer restricted stock units ("RSUs") vested in full pursuant to the terms of the agreements governing such Issuer RSUs. Pursuant to the Merger Agreement, immediately prior to the Effective Time, the Issuer RSUs were cancelled and converted into a right to receive the Merger Consideration in respect of such Issuer RSUs and cash in lieu of any fractional shares of Class A common stock of Ginkgo.

F2: Immediately prior to the Effective Time, all outstanding Issuer stock options vested in full pursuant to the terms of the agreements governing such stock options. Pursuant to the Merger Agreement, at the Effective Time, each Issuer stock option with an exercise price per share equal to or greater than the Merger Consideration Value (as defined in the Merger Agreement) was cancelled for no consideration.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 17, 2012 Filed Dec 19, 2012 21:02 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantRestricted Share Units · Derivative	21,689	$0.00	$0.00	Disclosure SEC source: 0000200406-12-000157 · edgar.xml · derivative · entry 1 PETERSON SANDRA E · CIK 0001192752 · Group Worldwide Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,689 Underlying: Common Stock · 21,689 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock. F2 · derivative.expiration_date: The Restricted Share Units vest on the first anniversary of the grant date. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.